HIV testing in early clinical trials: Who should decide whether it is warranted?

Journal of Clinical Pharmacology

Volumn 42, Issue 6, 2002, Pages 601-604

  Apseloff, Glen ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; CLINDAMYCIN; COTRIMOXAZOLE; KETOCONAZOLE; RIFAMPICIN;

DECISION MAKING; DRUG RESEARCH; DRUG SAFETY; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PHASE 1 CLINICAL TRIAL; RASH; REVIEW; SCREENING TEST; SLEEP DISORDER; VOLUNTEER; ARTICLE; CLINICAL TRIAL; DRUG DESIGN;

CLINICAL TRIALS; DRUG DESIGN; HIV INFECTIONS; HUMAN; HUMANS;

EID: 0036000309     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/00970002042006002     Document Type: Review

References (22)

1. Impairment of in vitro immune responses occurs within 3 months after HIV-1 seroconversion
2. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men
3. Activation of alveolar macrophages in asymptomatic HIVinfected individuals
4. Progressive and selective impairment of IL-3 and IL-4 production by peripheral blood CD4+ T-lymphocytes during the course of HIV-1 infection
5. Immunologic parameters in early-stage HIV-seropositive subjects associated with vaccine responsiveness
6. Neuropathology of human immunodeficiency virus infection at different disease stages
7. MR of head and neck adenopathy in asymptomatic HIV-seropositive men
8. Cerebrospinal fluid abnormalities in patients without AIDS who are seropositive for the human immunodeficiency virus
9. Human immunodeficiency virusassociated meningitis
10. Activation of virus replication after vaccination of HIV-1-infected individuals
11. Vaccination and HIV: A review of the literature
12. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals
13. Glutathione deficiency and HIV
14. Glutathione depletion in HIV-infected patients: Role of cysteine deficiency and effect of oral N-acetylcysteine
15. HIV-1 Tat potentiates TNF-induced NF-κB activation and cytotoxicity by altering the cellular redox state
16. Pathogenesis of hypersensitivity reactions to drugs in patients with HIV infection: Allergic or toxic?
17. The association of opportunistic infections with the occurrence of trimethoprim/sulfamethoxazole hypersensitivity in patients infected with human immunodeficiency virus
18. Cutaneous reactions to trimethoprimsulphametrole in AIDS patients treated for Pneumocystis carinii pneumonia
19. Drug intolerance in HIV disease
20. Sleep disturbances in men with asymptomatic human immunodeficiency (HIV) infection
21. A controlled study of early neurologic abnormalities in men with asymptomatic human immunodeficiency virus infection
22. Altered patterns of drug metabolism in patients with acquired immunodeficiency syndrome